Company Filing History:
Years Active: 2025
Title: Jung Hyun Her: Innovator in Chimeric Antigen Receptor Technology
Introduction
Jung Hyun Her is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on chimeric antigen receptors (CARs). His research focuses on enhancing the anticancer activity of immune cells, which has the potential to revolutionize cancer treatment.
Latest Patents
Jung Hyun Her holds a patent for a chimeric antigen receptor and natural killer cells expressing the same. This invention provides a chimeric antigen receptor that includes an intracellular signaling domain featuring the whole or a portion of an OX40 ligand (CD252). This advancement is notable for its excellent effects in increasing the anticancer activity of immune cells.
Career Highlights
Jung Hyun Her is associated with Gc Cell Corporation, where he continues to develop innovative solutions in the field of cancer immunotherapy. His work is characterized by a commitment to improving the efficacy of treatments available to patients suffering from cancer.
Collaborations
Some of his notable coworkers include Yu Kyeong Hwang and Sung Yoo Cho, who contribute to the collaborative efforts in advancing research and development in their field.
Conclusion
Jung Hyun Her's contributions to the development of chimeric antigen receptors represent a significant step forward in cancer treatment. His innovative approach and dedication to research continue to inspire advancements in immunotherapy.